EP Patent

EP4223876A4 — Double-stranded RNA for inhibiting the production of hepatitis B virus protein and pharmaceutical composition

Assigned to Fujifilm Corp · Expires 2025-12-10 · 0y expired

What this patent protects

Patent listed against dordaviprone-hydrochloride.

Drugs covered by this patent

dordaviprone-hydrochloride (DORDAVIPRONE HYDROCHLORIDE)

Patent Metadata

Patent number: EP4223876A4
Jurisdiction: EP
Classification: —
Expires: 2025-12-10
Drug substance claim: No
Drug product claim: No
Assignee: Fujifilm Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.